Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
D GennéD Lew

Abstract

To determine the causes of treatment failure and to evaluate the prognostic factors in patients hospitalized for community-acquired pneumonia, a prospective, observational study of 228 adult patients hospitalized for a community-acquired pneumonia in the University Hospital of Geneva and the La Chaux-de-Fonds Community Hospital, Switzerland, was conducted. The percentage of patients who failed to improve (as defined by guidelines of the Infectious Disease Society of America) and the causes of treatment failure were assessed, and patients who failed to improve under antimicrobial therapy were compared with those who did improve. In the 54 (24%) patients who failed to improve, a mean increase in length of hospitalization of 4 days was observed. Most causes of treatment failure could be attributed to host factors (61%) rather than to the pathogen (16%) or to an inappropriate antibiotic regimen (3%). After adjusting for potentially confounding variables, concomitant neoplasia (OR 3.25; 95%CI 1.11-9.56), neurological disease (OR 2.34; 95%CI 1.07-5.13), and aspiration pneumonia (OR 2.97; 95%CI 29-6.86]) were associated with failure to improve, whereas monocytosis improved prognosis (OR 0.40; 95%CI 0.20-0.80). Almost one out of four p...Continue Reading

References

Jan 1, 1975·Acta Haematologica·G MeuretH van Lessen
Feb 1, 1992·The Journal of Dermatology·T TsukaharaY Horiuchi
Aug 1, 1991·The American Review of Respiratory Disease·A TorresR Rodriguez-Roisin
Aug 1, 1973·Annals of Internal Medicine·E Klemola
Dec 14, 1995·The New England Journal of Medicine·J G Bartlett, L M Mundy
May 1, 1995·The Medical Clinics of North America·B A Cunha, A M Ortega
Jan 10, 1996·JAMA : the Journal of the American Medical Association·M J FineW N Kapoor
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jul 14, 1997·Archives of Internal Medicine·J P MetlayM J Fine
May 26, 1998·JAMA : the Journal of the American Medical Association·E A HalmD E Singer
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian
Oct 21, 1998·Infectious Disease Clinics of North America·T J Marrie
Jul 21, 2000·American Journal of Respiratory and Critical Care Medicine·F ArancibiaA Torres
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettM J Fine
Jan 3, 2001·The New England Journal of Medicine·C G WhitneyUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
Nov 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Committee
Apr 12, 2003·American Journal of Respiratory and Critical Care Medicine·Ali A El-SolhNancy Gifford
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN Infectious Diseases Society of America
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D GennéD Lew
Mar 10, 2004·Archives of Internal Medicine·Beatriz RosónFrancesc Gudiol

❮ Previous
Next ❯

Citations

May 3, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T Welte
Jul 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H KollefJohn Segreti
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nick DanemanDavid N Fisman
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick G P CharlesM Lindsay Grayson
Dec 3, 2008·Journal of the American Veterinary Medical Association·David A KoganRachel E Pollard
Dec 4, 2012·Journal of Microbiological Methods·R MonnoG Miragliotta
Feb 13, 2013·Infectious Disease Clinics of North America·Timothy WiemkenJulio Ramirez
Nov 30, 2010·European Journal of Internal Medicine·Agustín Ruiz-GonzálezRegino Serrano
Oct 31, 2013·Journal of the American Association of Nurse Practitioners·Cherese SeversonMeg Fitzhugh
Aug 20, 2015·The Journal of Small Animal Practice·C DeroyA Hamaide
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Sep 8, 2016·Journal of the American Medical Directors Association·Alain PutotPatrick Manckoundia
Feb 1, 2013·Therapeutic Advances in Infectious Disease·João Gonçalves-PereiraPedro Póvoa
Feb 13, 2018·Current Opinion in Pulmonary Medicine·Otavio T RanzaniAntoni Torres
Jul 21, 2009·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Ricardo de Amorim CorrêaUNKNOWN Comissão de Infecções Respiratórias e Micoses - Sociedade Brasileira de Pneumologia e Tisiologia
Sep 14, 2020·BMC Infectious Diseases·Xiudi HanUNKNOWN CAP-China network
Oct 16, 2021·JAMA Network Open·Aurélien DinhUNKNOWN Pneumonia Short Treatment (PTC) Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.